![](https://investorshub.advfn.com/uicon/521970.png?cb=1579207683)
Monday, May 17, 2021 8:21:24 AM
It didnt matter then, doesn’t matter now, and will never matter.
Those who actually research: spend big money. Regens future is not typical. The past wasnt great. mRNA was tough to fund. And well toxic debt turned the tables fast in the end. But we do have a boatload of incredbly advanced mRNA/siRNA IP. So really, once the dilution ended... how bad? We have billions in IP from not too much debt. In the Biotech world: We are in incredible shape. Look at who surrounds Regen. Past, Present, and who is likely to join!
The dilution is to a drip, if that. Its go time.
10k this week. Watch.
Sometimes its Skil, Sometimes its Luc.
I’d rather have 1 genuine team follower then 100 look-a-likes.
Appreciate Member Marks!
ALL IMHO
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM